|Articles|October 19, 2017
Novum Selects OmniComm as Strategic EDC Partner
Advertisement
Novum Pharmaceutical Research Services has selected TrialMaster electronic data capture technology from OmniComm Systems, Inc to support their clinical research. Novum with the use of TrialMaster will conduct more than 200 research studies annually due to the flexibility, ease of use, and capabilities that TrialMaster provides.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Accelerating Site Payments with Agentic AI: See it in Action
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
